| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |